Clinical Trial Update: Cannabidiol's Role in Dementia Management [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update shows Phase 2 and Phase 3 studies evaluating cannabidiol for dementia management, including vascular dementia and mixed dementia, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dementia
• Vascular Dementia

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Hospital Pengajar Universiti Putra Malaysia | Conditions: Dementia, Vascular, Dementia, Mixed | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING